Tokyo - The Asia Pacific Medical Technology Association (APACMed), representing manufacturers and suppliers of medical equipment, devices and in vitro diagnostics, as well as national industry associations, strengthens ties with Japans' largest medical device promoting body, the Japan Federation of Medical Devices Associations (JFMDA). Founded over three decades ago, JFMDA comprises 21 associations

MINNEAPOLIS - A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology?, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele. Brain derived neurotrophic factor (BDNF) is a protein...

BIRMINGHAM, Ala. - Human skin is the body's largest organ, providing protection to muscles, bones, ligaments and organs. According to the Centers for Disease Control and Prevention, skin cancer is the most common type of cancer in the United States. "Skin cancer, like all types of cancer, is capable of destroying healthy tissue and spreading to distant body sites," said C. Blake Phillips, M.D., a fellow in...

CHAPEL HILL, N.C. - It's a fat-burning secret anyone interested in bone health should know. For the first time, UNC School of Medicine researchers show that exercising burns the fat found within bone marrow and offers evidence that this process improves bone quality and the amount of bone in a matter of weeks. The study, published in the Journal of Bone and Mineral Research, also suggests obese...

Sydney, Australia & Auckland, New Zealand - Living Cell Technologies Limited has initiated a research collaboration with the Centre for Brain Research (CBR) at the University of Auckland. The research collaboration will explore how LCT's products can reverse human brain neurodegenerative processes associated with pericytes (and other brain cells), which help sustain the blood-brain barrier...

Dr. Rita P.-Y. Chen, an Associate Research Fellow at the Institute of Biological Chemistry along with Dr. Pang-hsien Tu, a former Assistant Research Fellow at the Institute of Biomedical Sciences, and their research teams recently found that a modified short peptide delays the onset of Alzheimer's disease when delivered in the form of a nasal drop in a mouse model. The research was published in...

TLC announced that its oncology drug candidate TLC178 has been designated as a drug for a rare pediatric disease in the treatment of rhabdomyosarcoma (RMS) by the U.S. Food and Drug Administration (FDA). This designation brings the company closer to receiving a Rare Pediatric Disease Priority Review Voucher, which can be used to expedite the review process or transferred to another...